| |
|
Form Serial Number: |
DA20250605E00427
|
| 1.
Date of relevant event: |
04/06/2025
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
04/06/2025
(dd/mm/yyyy)
|
| 3.
Stock code: |
02453 |
| 4.
Name of listed corporation: |
Concord Healthcare Group Co., Ltd. |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
265,151,024 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
YANG |
| (Other names) |
Jianyu |
|
|
|
| 10.
Name of director (Chinese): |
杨建宇 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1213 | The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
|
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 96,659,100 | 39.20 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 96,659,100 | 36.45 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Morgancreek Investment Holdings Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | YANG Jianyu | 100.00 | N | |
| Concord Medical Services Holdings Limited | Scotia Centre, 4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman Islands; Cayman Islands | Morgancreek Investment Holdings Limited | 73.20 | N | |
| Ascendium Group Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | Concord Medical Services Holdings Limited | 100.00 | N | |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | N | |
| Tianjin Concord Medical Technology Co., Ltd. | K52. 11/F, Door 2, Block D, No. 1 Gonghua Road, Huayuan Industrial Zone, Binhai High Tech Zone, Tianjin, PRC; People's Republic of China | Medstar (Shanghai) Enterprise Management Co., LTD | 100.00 | Y | |
| Concord Hospital Management Group Limited | Room 1701, 9 Chong Yip Street, Kwun Tong, Kowloon, Hong Kong; Hong Kong | Ascendium Group Limited | 100.00 | N | |
| Beijing Concord Medical Technology Co., Ltd. | Room 2702, Block A, No. 36, North Third Ring East Road, Dongcheng District, Beijing, PRC; People's Republic of China | Concord Hospital Management Group Limited | 100.00 | Y | |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Due to the completion of the placement of new H shares under the general mandate on 4 June 2025, which increased the total number of issued H shares of the listed corporation from 246,551,024 H shares to 265,151,024 H shares (as detailed in the listed corporation's announcements dated 29 May 2025 and 4 June 2025), the percentage shareholding interest of the substantial shareholder in the listed corporation's H shares has been diluted.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
05/06/2025
(dd/mm/yyyy)
|
| |
